Cargando…
Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD?
Drug classes used in the treatment of Chronic Obstructive Pulmonary Disease (COPD) have not changed for many years, and none to date have shown disease-modifying activity. Statins are used to help reduce cardiovascular risk, which is high in many patients with COPD. Their use has been associated wit...
Autores principales: | Walton, Georgia M., Stockley, James A., Griffiths, Diane, Sadhra, Charandeep S., Purvis, Thomas, Sapey, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086591/ https://www.ncbi.nlm.nih.gov/pubmed/27727158 http://dx.doi.org/10.3390/jcm5100089 |
Ejemplares similares
-
Getting stuck or choosing to stay? Neutrophil transit times in the lung in acute inflammation and COPD
por: Sapey, Elizabeth, et al.
Publicado: (2019) -
Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors?
por: Hobbins, Stephanie, et al.
Publicado: (2017) -
Catching “Early” COPD – The Diagnostic Conundrum
por: Yip, Kay Por, et al.
Publicado: (2021) -
Understanding the role of neutrophils in chronic inflammatory airway disease
por: Jasper, Alice E, et al.
Publicado: (2019) -
Small Airways Response to Bronchodilators in Adults with Asthma or COPD: A Systematic Review
por: Almeshari, Mohammed A, et al.
Publicado: (2021)